Arcutis Biotherapeutics, Inc.

Ownership Transactions Reported by 23 Insiders

Symbol
ARQT on Nasdaq
Industry
Pharmaceutical Preparations
Location
3027 Townsgate Road, Suite 300, Westlake Village, CA

Insiders trading volume in the past year

Arcutis Biotherapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Frazier Life Sciences VIII, L.P. 10%+ Owner $31.3M Oct 24, 2023
Todd Franklin Watanabe Reporting Person's title: President and Chief Executive Officer, Director $19.5M -$1.24M -5.97% Mar 24, 2025
Bhaskar Chaudhuri Director $7.29M Jun 14, 2024
David Topper Chief Financial Officer $2.89M -$262K -8.32% Apr 2, 2025
Masaru Matsuda Reporting Person's title: General Counsel and Corporate Secretary $2.73M -$297K -9.83% Feb 28, 2025
Larry Todd Edwards Reporting Person's title: Executive Vice President, Chief Commercial Officer $2.48M -$126K -4.82% Feb 28, 2025
Howard G. Welgus Director $1.84M -$1.24M -40.2% Apr 1, 2025
Patrick Burnett Reporting Person's title: Executive Vice President, Chief Medical Officer $1.83M -$3.01M -62.1% Mar 13, 2025
Orbimed Advisors Llc 10%+ Owner $1.47M Jun 24, 2022
Matthew Richard Moore SVP and Chief Business Officer $1.27M -$40.9K -3.12% May 1, 2024
David W. Osborne Chief Technical Officer $952K Mar 6, 2023
John W. Smither Chief Financial Officer $541K Feb 13, 2024
Kenneth A. Lock Chief Commercial Officer $225K Mar 6, 2023
Patricia A. Turney SVP, Operations $223K Mar 6, 2023
Scott L. Burrows Chief Financial Officer $209K Mar 6, 2023
Keith R. Leonard Director $165K Jun 14, 2024
Sue Jean Lin Director $153K Jun 14, 2024
Halley E. Gilbert Director $151K Jun 14, 2024
Patrick J. Heron Director, 10%+ Owner $151K Jun 14, 2024
Neha Krishnamohan Director $126K Jun 14, 2024
Terrie Curran Director $110K -$94.2K -46.1% Nov 11, 2024
Joseph L. Turner Director $15.3K Jun 1, 2022
Ricky Sun Director Jun 9, 2021

Recent Insider Transactions by Companies or Individuals for Arcutis Biotherapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.